BusinessI-MED Pharma's I-PEN® Does Not Infringe the TearLab PatentBy Nasdaq OMXFeb 20, 2018, 8:44 PM UTC
BusinessI-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.By Nasdaq OMXJan 8, 2018, 6:02 PM UTC
BusinessI-PEN®, I-DROP® and I-PLUG® now available in Spain and Portugal through Partnership with IMEXBy Nasdaq OMXJan 8, 2018, 2:16 PM UTC
BusinessDry Eye Syndrome Treatment Market to be worth US$ 6,610 Mn by 2027; Launch of Innovative Products to Drive Growth of Market, Notes FMIBy Nasdaq OMXDec 13, 2017, 8:56 AM UTC
BusinessI-PEN®, I-DROP® and I-LID’N LASH® will be available in Denmark, Sweden and NorwayBy Nasdaq OMXOct 6, 2017, 7:17 PM UTC
